420 related articles for article (PubMed ID: 15276470)
1. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
6. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
7. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
Pu WT; Ma Q; Izumo S
Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
[TBL] [Abstract][Full Text] [Related]
8. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
10. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.
Diedrichs H; Chi M; Boelck B; Mehlhorn U; Schwinger RH
Eur J Heart Fail; 2004 Jan; 6(1):3-9. PubMed ID: 15012912
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
Yatani A; Honda R; Tymitz KM; Lalli MJ; Molkentin JD
J Mol Cell Cardiol; 2001 Feb; 33(2):249-59. PubMed ID: 11162130
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation.
Larrieu D; Thiébaud P; Duplàa C; Sibon I; Thézé N; Lamazière JM
Exp Cell Res; 2005 Oct; 310(1):166-75. PubMed ID: 16129432
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.
Lipskaia L; Pourci ML; Deloménie C; Combettes L; Goudounèche D; Paul JL; Capiod T; Lompré AM
Circ Res; 2003 May; 92(10):1115-22. PubMed ID: 12730091
[TBL] [Abstract][Full Text] [Related]
17. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
20. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]